Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

The therapeutic impacts of tocotrienols in type 2 diabetic patients with hyperlipidemia.

Baliarsingh S, Beg ZH, Ahmad J.

Atherosclerosis. 2005 Oct;182(2):367-74. Epub 2005 Apr 20.

PMID:
16159610
2.

Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients.

Daud ZA, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, Khosla P.

Vasc Health Risk Manag. 2013;9:747-61. doi: 10.2147/VHRM.S51710. Epub 2013 Nov 28.

3.

A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.

Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.

Clin Ther. 2003 Apr;25(4):1074-95.

PMID:
12809958
5.

Diabetic dyslipidemia.

Kreisberg RA.

Am J Cardiol. 1998 Dec 17;82(12A):67U-73U; discussion 85U-86U. Review.

PMID:
9915665
6.

Protective effects of tocotrienols against lipid-induced nephropathy in experimental type-2 diabetic rats by modulation in TGF-β expression.

Siddiqui S, Ahsan H, Khan MR, Siddiqui WA.

Toxicol Appl Pharmacol. 2013 Dec 1;273(2):314-24. doi: 10.1016/j.taap.2013.09.004. Epub 2013 Sep 14.

PMID:
24041758
8.

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.

Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group.

Coron Artery Dis. 2001 Aug;12(5):413-23.

PMID:
11491207
9.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

Bays HE, Goldberg RB, Truitt KE, Jones MR.

Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.

PMID:
18852398
11.

Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.

Krempf M, Berthezène F, Wemeau JL, Moinade S, Desriac I, Amelineau E, Passa P.

Diabetes Metab. 1997 Apr;23(2):131-6.

13.

Comparative hypoglycemic and nephroprotective effects of tocotrienol rich fraction (TRF) from palm oil and rice bran oil against hyperglycemia induced nephropathy in type 1 diabetic rats.

Siddiqui S, Rashid Khan M, Siddiqui WA.

Chem Biol Interact. 2010 Dec 5;188(3):651-8. doi: 10.1016/j.cbi.2010.08.010. Epub 2010 Sep 28.

PMID:
20816776
16.

Lipoprotein abnormalities and their consequences for patients with type 2 diabetes.

Krentz AJ.

Diabetes Obes Metab. 2003 Nov;5 Suppl 1:S19-27. Review.

PMID:
14984018
17.

Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes--the Stop Atherosclerosis in Native Diabetics Study (SANDS).

Russell M, Fleg JL, Galloway WJ, Henderson JA, Howard J, Lee ET, Poolaw B, Ratner RE, Roman MJ, Silverman A, Stylianou M, Weir MR, Wilson C, Yeh F, Zhu J, Howard BV.

Am Heart J. 2006 Nov;152(5):867-75.

PMID:
17070147
18.

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

J Clin Pharm Ther. 2006 Aug;31(4):375-83.

PMID:
16882108
19.

Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial.

Kianbakht S, Dabaghian FH.

Complement Ther Med. 2013 Oct;21(5):441-6. doi: 10.1016/j.ctim.2013.07.004. Epub 2013 Aug 6.

PMID:
24050577
20.

Muraglitazar, a dual (alpha/gamma) PPAR activator: a randomized, double-blind, placebo-controlled, 24-week monotherapy trial in adult patients with type 2 diabetes.

Buse JB, Rubin CJ, Frederich R, Viraswami-Appanna K, Lin KC, Montoro R, Shockey G, Davidson JA.

Clin Ther. 2005 Aug;27(8):1181-95.

PMID:
16199244
Items per page

Supplemental Content

Write to the Help Desk